Published

Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in Public Health
Date: 2026-06-17
Source: Crossref
DOI: 10.3389/fpubh.2026.1845943
PubMed: 42395285

Authors

Leeman Lawrence Armstrong Maya Menashi Dara Nayo-Washington Hanifa Marseille Elliot Herrera Janus Romero Crystal Page-Reeves Janet

Watch author

Derived topics and classifications

psilocybin PTSD Aging Clinical Trial Veterans Healthcare Workers Safety Clinical Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.3389/fphar.2018.00100 10.1177/02698811251362390 10.1001/jama.2023.14530 10.1097/mlr.0b013e3182408812 10.3389/frhs.2024.1414969 10.2105/ajph.93.8.1261 10.1176/ajp.156.1.5 10.1093/tbm/ibae053 10.1038/s41562-025-02103-x 10.1186/s13011-020-00264-8 10.1007/s40501-020-00234-8 10.1177/02698811211008567

Indexed papers citing this DOI

Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico2026-06-17

Related papers

Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot StudyClinicalTrials.gov · 2026-03-18 Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling.Therapeutic advances in drug safety · 2026-01-01 Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert opinion on drug safety · 2022-06-01 Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin CompoundsACS Omega · 2025-09-30 Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms.Drug safety · 2025-05-01 Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents.Expert opinion on drug safety · 2023-01-01 [DNA and chemical analyses of commercial fly agaric-related products].Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan · 2005-04-01 [Discrimination of psychoactive fungi (commonly called "magic mushrooms") based on the DNA sequence of the internal transcribed spacer region].Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan · 2003-02-01